MedTrace Logo

Effects of Vitamin D on Inflammation in Liver Disease

NCT01754961 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-12-21

No results posted yet for this study

Summary

Chronic liver diseases are associated with inflammation. The investigators postulate that Vitamin D may modulate inflammation. Thus the investigators will study the effect of Vitamin D replacement in patients with Hepatitis C infection and Vitamin D deficiency.

Conditions

  • Hepatitis C Infection
  • Vitamin D Deficiency

Interventions

DRUG

Vitamin D

Vitamin D 500,000 IU given orally on Day 1

DRUG

Placebo

Placebo given orally on Day 1

Sponsors & Collaborators

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Mario Chojkier, MD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-10-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01754961 on ClinicalTrials.gov